The U.S. Food and Drug Administration (FDA) has recorded a regulatory status change for a topical product containing hydrocortisone. The product, identified as HYDROCORTISONE 0.5% OINTMENT (product number 003), is manufactured by Perrigo New York. According to the FDA’s database, the product is classified as a non‑reference drug and is now marked as "Discontinued" under the Abbreviated New Drug Application (ANDA) number ANDA084969. No reference standard is associated with this submission.
Key details:
- Route: Topical
- Dosage form: Ointment
- Active ingredient: Hydrocortisone 0.5%
- Sponsor: Perrigo New York
- Marketing status: Discontinued
- Application number: ANDA084969
Actualizaciones regulatorias28 sept 2026•1 min de lectura
FDA Discontinues Hydrocortisone 0.5% Ointment (ANDA084969)
The FDA has listed the hydrocortisone 0.5% topical ointment (product 003) from Perrigo New York as discontinued under application ANDA084969.
Recopilado por el equipo de PharmaCountry · Fuente: FDA.gov
Calificaciones
(0)
(0)
(0)
(0)
(0)
Más artículos
Ver todos los artículosInvestigación e Informes
Global Finished Dosage Manufacturing Landscape 2026
5 oct 2026
Actualizaciones regulatoriasKorea Korus hit with 1‑month manufacturing suspension over missing post‑marketing safety test
28 sept 2026
AnálisisPharma distributors set delivery cut‑offs ahead of Chuseok holiday (Sep 21‑23)
28 sept 2026
Deja tu valoración